MEPERIDINE HYDROCHLORIDE

Post-LOE

meperidine hydrochloride

Hikma

ANDAORALTABLET

Approved

Mar 1997

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

3/8 — Basic

MEPERIDINE HYDROCHLORIDE (meperidine hydrochloride) by Hikma is morphine; the most prominent of these involve the central nervous system and organs composed of smooth muscle. Approved for pain, severe enough to require an opioid analgesic, for which alternative treatments are inadequate. First approved in 1997.

Drug data last refreshed 18h ago

Mechanism of Action

morphine; the most prominent of these involve the central nervous system and organs composed of smooth muscle. The principal actions of therapeutic value are analgesia and sedation.

Indications (3)

pain severe enough to require an opioid analgesic

Worked on MEPERIDINE HYDROCHLORIDE at Hikma? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.